Zobrazeno 1 - 10
of 320
pro vyhledávání: '"van der Kuy P"'
Autor:
van der Groef R, de Jong PHP, Hijnen DJ, van der Woude CJ, van Laar JAM, van der Kuy PHM, Brugma JD, Pasma A
Publikováno v:
Patient Preference and Adherence, Vol Volume 17, Pp 167-174 (2023)
Romy van der Groef,1 Pascal HP de Jong,1 Dirk Jan Hijnen,2 Christien J van der Woude,3 Jan AM van Laar,4 P Hugo M van der Kuy,5 Jan-Dietert Brugma,6 Annelieke Pasma1 1Department of Rheumatology, Erasmus University Medical Center, Rotterdam, the Nethe
Externí odkaz:
https://doaj.org/article/ea7b8f7f9d1f4f70a3b208ee8d989c06
Autor:
Mestres Gonzalvo C, Hurkens KPGM, de Wit HAJM, van Oijen BPC, Janknegt R, Schols JMGA, Mulder WJ, Verhey FR, Winkens B, van der Kuy PHM
Publikováno v:
Therapeutics and Clinical Risk Management, Vol 2015, Iss default, Pp 767-777 (2015)
Carlota Mestres Gonzalvo,1 Kim PGM Hurkens,2 Hugo AJM de Wit,3 Brigit PC van Oijen,1 Rob Janknegt,1 Jos MGA Schols,4 Wubbo J Mulder,5 Frans R Verhey,6 Bjorn Winkens,7 Paul-Hugo M van der Kuy1 1Department of Clinical Pharmacology and Toxicology, Orbis
Externí odkaz:
https://doaj.org/article/9ebea4188bac41419417faa3f0cc131b
Autor:
Ngoc H. Tan, Melvin Lafeber, Roos S. G. Sablerolles, Isabelle Veerman Roders, Anna van de Hoef, Karenin van Grafhorst, Leo G. Visser, Douwe F. Postma, Abraham Goorhuis, Wim J. R. Rietdijk, P. Hugo M. van der Kuy
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-8 (2024)
Abstract Background Electronic informed consent (eConsent) usage has expanded in recent years in Europe, especially during the pandemic. Slow recruitment rate and limitations in participant outreach are the challenges often faced in clinical research
Externí odkaz:
https://doaj.org/article/f9ff3defdbea4d9dbc89791a2492116c
Autor:
Wim J. R. Rietdijk, Madzy Maljaars-Hendrikse, Monique van Dijk, Romana F. Malik, Ngoc Tan, P. Hugo M. van der Kuy
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundAn open organizational culture in the workplace represents an environment where information, ideas, and feedback are freely exchanged among all members, regardless of position or rank. Currently, there are no valid survey instruments to mea
Externí odkaz:
https://doaj.org/article/b284bbb4f1124fe8bc4c1e4dd27eda1e
Autor:
Luca M. Zaeck, Ngoc H. Tan, Wim J. R. Rietdijk, Daryl Geers, Roos S. G. Sablerolles, Susanne Bogers, Laura L. A. van Dijk, Lennert Gommers, Leanne P. M. van Leeuwen, Sharona Rugebregt, Abraham Goorhuis, Douwe F. Postma, Leo G. Visser, Virgil A. S. H. Dalm, Melvin Lafeber, Neeltje A. Kootstra, Anke L. W. Huckriede, Bart L. Haagmans, Debbie van Baarle, Marion P. G. Koopmans, SWITCH-ON Research Group, P. Hugo M. van der Kuy, Corine H. GeurtsvanKessel, Rory D. de Vries
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-12 (2024)
Abstract Waning antibody responses after COVID-19 vaccination combined with the emergence of the SARS-CoV-2 Omicron lineage led to reduced vaccine effectiveness. As a countermeasure, bivalent mRNA-based booster vaccines encoding the ancestral spike p
Externí odkaz:
https://doaj.org/article/7b4e0251847c419a88ac331e321a07cb
Autor:
NA Zwietering, AEMJH Linkens, D Kurstjens, PHM van der Kuy, N van Nie-Visser, BPA van de Loo, KPGM Hurkens, B Spaetgens
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Drug-related problems (DRPs) and potentially inappropriate prescribing (PIP) are associated with adverse patient and health care outcomes. In the setting of hospitalized older patients, Clinical Decision Support Systems (CDSSs) co
Externí odkaz:
https://doaj.org/article/d63aec4ef82a4205809ca67f63237ed1
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Health authorities use value-based pricing models to determine the value of innovative drugs and to establish a price. Pharmaceutical companies prefer value-based pricing over cost-based pricing. It is ambiguous whether value-based pricing has the sa
Externí odkaz:
https://doaj.org/article/0f3107b91e954dd98473a59dfca9b17b
Autor:
Elsten, Eline E.C.M., Pot, Iris E., Geijteman, Eric C.T., Hedman, Christel, van der Heide, Agnes, van der Kuy, P. Hugo M., Fürst, Carl-Johan, Eychmüller, Steffen, van Zuylen, Lia, van der Rijt, Carin C.D.
Publikováno v:
In Journal of Pain and Symptom Management November 2024 68(5):443-455
Autor:
Fryer, Holly A., Geers, Daryl, Gommers, Lennert, Zaeck, Luca M., Tan, Ngoc H., Jones-Freeman, Bernadette, Goorhuis, Abraham, Postma, Douwe F., Visser, Leo G., Hogarth, P. Mark, Koopmans, Marion P.G., GeurtsvanKessel, Corine H., O’Hehir, Robyn E., van der Kuy, P. Hugo M., de Vries, Rory D., van Zelm, Menno C.
Publikováno v:
In Journal of Infection October 2024 89(4)
Autor:
M.A.M. van Hylckama Vlieg, I.E. Pot, H.P.J. Visser, M.A.C. Jong, M.J.D.L. van der Vorst, B.J. van Mastrigt, J.N.A. Kiers, P.P.P.H. van den Homberg, M.F. Thijs-Visser, E. Oomen-de Hoop, A. van der Heide, P.H.M. van der Kuy, C.C.D. van der Rijt, E.C.T. Geijteman
Publikováno v:
BMC Palliative Care, Vol 23, Iss 1, Pp 1-8 (2024)
Abstract Background Polypharmacy is common among patients with a limited life expectancy, even shortly before death. This is partly inevitable, because these patients often have multiple symptoms which need to be alleviated. However, the use of poten
Externí odkaz:
https://doaj.org/article/77ecba2dec69488fa6c7641571117813